NCT03695575

Brief Summary

The cochlea, the sensory organ of hearing, is a structure of the temporal bone on the skull. In everyday life sounds are heard via air conduction. This means that vibrations in the air are conducted through our ear canals, via the eardrum and the middle-ear bones, to the cochlea. However, vibrations can be conducted to the cochlea via the bones of the head. Bone-conduction headsets have become popular for recreational use (for example cyclists and runners wear them to listen to music while exercising). When in a noisy environment, if a speech signal is delivered to a microphone connected via Bluetooth to the bone conduction headset, the person wearing the headset receives the speech signal as if the talker were closer to them. The ratio between the speech level and the noise level (SNR, signal-to-noise ratio) is increased, so that it is easier to understand the spoken message. A previous study carried out by the investigators has shown that this may help children with hearing loss due to otitis media with effusion ('glue ear'). The aim of the current study is to explore the potential of the headset to help children with auditory processing disorder (APD). Typically, children with APD have normal audiograms, but, in spite of this, they struggle to understand speech in a background noise. The headset can deliver the speech message to them. Currently, FM systems are used for children with APD in the classroom. These systems are effective, but their cost is high and provision may be limited. The feasibility of the use of the headset in a group of children with normal audiometric thresholds will be assessed. The study hypothesis is that using a bone-conduction headband improves speech recognition in noise and decreases listening effort even when air-conduction hearing thresholds are normal. Measures of speech recognition and listening effort will be done in quiet and in noise with and without the bone-conduction headset in order to measure the effect of using the headset on speech recognition when hearing thresholds are normal.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 4, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 31, 2019

Status Verified

January 1, 2019

Enrollment Period

6 months

First QC Date

September 25, 2018

Last Update Submit

January 30, 2019

Conditions

Keywords

Bone ConductionAssistive Listening DevicesListening EffortSpeech in Noise

Outcome Measures

Primary Outcomes (1)

  • Mc Cormick Toy Test

    The main outcome measure will be an age-appropriate speech test. This test is called "McCormick Toy Test" and it consists in measuring the level needed for the child to identify 71% the words in a closed-set list. A minimum of three reversals is needed to determine the outcome. The outcome is the level of speech in dB (A). Lower levels indicate better performance. The test will be performed in quiet and in noise, with and without the headset. The statistical analysis will depend on the characteristics of the data. Because the data are discrete, performing Analysis of Variance (ANOVA) will not be possible. Comparisons of thresholds obtained in different conditions will be done using non-parametric tests.

    Outcomes will be measured in a single session. Four runs are required. The total testing time is around 12 minutes.

Secondary Outcomes (2)

  • Listening Effort

    Outcomes will be measured in a single session. Four runs are required. The total testing time is around 12 minutes.

  • Wearability Questionnaire

    The questionnaire will be completed at the end of the session. Testing time is five minutes.

Study Arms (1)

Study sample

OTHER

A repeated-measures model will be used. This means that participants in a single arm will be tested in all conditions. Speech recognition and listening effort outcomes will be measured in two conditions: with and without a bone-conduction headset.

Device: Bone-conduction headset

Interventions

A bone-conduction headset paired with a microphone will be used.

Study sample

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 6 to 11 years old.
  • No developmental concerns
  • No concerns about hearing loss.
  • No concerns about language development.
  • English dominant language.

You may not qualify if:

  • History, risk, or parent/carer/teacher concern of hearing loss.
  • Developmental concerns
  • Suspected language disability.
  • Non-English dominant language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Childrens' Hearing Evaluation and Amplification Resource

Shepreth, Hertsfordshire, SG8 6QS, United Kingdom

Location

MeSH Terms

Conditions

Auditory Perceptual Disorders

Condition Hierarchy (Ancestors)

Auditory Diseases, CentralRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Tamsin M Brown, MBBS, RCPCH

    NHS (National Health Service): Cambridgeshire Community Services (CCS)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tamsin M Brown, MBBS, RCPCH

CONTACT

Marina Salorio-Corbetto, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2018

First Posted

October 4, 2018

Study Start

March 1, 2019

Primary Completion

September 1, 2019

Study Completion

December 1, 2019

Last Updated

January 31, 2019

Record last verified: 2019-01

Locations